The multispecialty team at the Kellogg Cancer Center provides each patient with a personalized care plan to create the path for the most optimal outcome, including recommendations for advanced diagnostics, participation in promising clinical trials, and complete follow-up care that encompasses dietary counseling and rehabilitation.  NorthShore University HealthSystem’s team of hematologists manages and oversees a patient’s care from diagnosis through treatment, coordinating with other specialists as needed.

For most patients with Hodgkin’s lymphoma, chemotherapy alone or chemotherapy with radiation therapy is effective.  Patients with non-Hodgkin’s lymphoma may be treated with radiotherapy, chemotherapy, or a combination of the two, depending on the specific type and stage of the disease. 

Highly specific monoclonal antibodies (such as Rituximab, Rituxan) directed at lymphoma cells are used for initial treatment, and recurrence of some types of non-Hodgkin’s lymphoma.  These targeted therapies have been shown to significantly improve response rates without increasing toxicity. 

Stem cell transplantation is sometimes a course of treatment that is chosen for patients with lymphoma.  Kellogg Cancer Center has an accredited program by The Foundation for the Accreditation of Cellular Therapy for autologous stem cell transplantation.

For More Information

Please call 847.570.2112 for more information or to schedule an appointment with one of our specialists.

× Alternate Text